<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02741232</url>
  </required_header>
  <id_info>
    <org_study_id>15075</org_study_id>
    <nct_id>NCT02741232</nct_id>
  </id_info>
  <brief_title>Comparison of Perioperative Opioid Consumption Following Pectoral Nerve Block for Breast Cancer Surgery</brief_title>
  <official_title>Comparison of Perioperative Opioid Consumption Following Pectoral Nerve Block Under General Anesthesia for Breast Cancer Surgery: A Randomized Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Maisonneuve-Rosemont Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Maisonneuve-Rosemont Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study, the investigators will compare the intraoperative opioid consumption for
      patients undergoing breast cancer surgery. The patients will be divided in two groups, the
      first one will receive a pectoral nerve block right after induction of anesthesia and the
      second one, the control group, will not receive the pectoral block. Our hypothesis is that
      the pectoral nerve block reduces the opioid consumption during the surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      After induction of general anesthesia with propofol, remifentanil and succinylcholine, the
      patients will be divided either in the pectoral block group or the control group (sham
      block). Both groups will receive the same perioperative and postoperative anesthetic
      protocol. The investigator in charge of the patient will leave the operative room right
      before the completion of the pectoral block (or the sham block) to preserve randomisation and
      the block will be performed by another investigator. The pectoral block is performed under
      ultrasound guidance with 10 cc of lidocaine 1% with epinephrine 1/400000 between the
      pectoralis major muscle and the pectoralis minor muscle and 20 cc of the same solution
      between the pectoralis minor muscle and the serratus anterior muscle at the third rib.
      Anesthesia will be maintained with sevoflurane for a bispectral (BIS) index between 45 and
      60. Analgesia will be provided with a perfusion of remifentanil adjusted to maintain a mean
      arterial blood pressure (MAP) in the range of ± 10% of the basal MAP (mean of the last three
      MAPs obtained before surgical incision, under sevoflurane-only anesthesia). The total
      remifentanil consumption will be assessed and compared between the groups. The investigators
      believe that the pectoral nerve block will significantly reduce the intraoperative
      remifentanil consumption.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2016</start_date>
  <completion_date type="Anticipated">August 2017</completion_date>
  <primary_completion_date type="Anticipated">August 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Intraoperative remifentanil consumption for the first 30 minutes of surgery</measure>
    <time_frame>30 minutes</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Total intraoperative remifentanil consumption</measure>
    <time_frame>2 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total intraoperative sevoflurane consumption</measure>
    <time_frame>2 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative pain evaluation</measure>
    <time_frame>30 minutes</time_frame>
    <description>using the numerical rating scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative nausea and vomiting evaluation</measure>
    <time_frame>30 minutes</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total time in the recovery room</measure>
    <time_frame>60 minutes</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative opioid consumption</measure>
    <time_frame>1 hour</time_frame>
    <description>dilaudid consumption</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Nerve Block</condition>
  <condition>Mastectomy</condition>
  <arm_group>
    <arm_group_label>Pectoral nerve block</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>After induction of general anesthesia and under ultrasound visual guidance, pectoral block is performed with 30 mL total of local anesthetic (1% lidocaine + 1/400000 epinephrine). 10 mL of local anesthetic between pectoralis major muscle and pectoralis minor muscle and 20 mL between pectoralis minor muscle and serratus anterior muscle at the third rib.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham block</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>No needle or injection will be used</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lidocaine 1% with epinephrine 1/400000</intervention_name>
    <arm_group_label>Pectoral nerve block</arm_group_label>
    <other_name>xylocaine with epinephrine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>sham block</intervention_name>
    <arm_group_label>Sham block</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ASA 1 to 3 inclusively

          -  breast cancer surgery with or without axillary dissection

        Exclusion Criteria:

          -  any contraindication to the pectoral nerve block (coagulopathy, infection, pre-
             existing neuropathy, local anesthetic allergy and refusal of local anesthesia)

          -  refusal to participate in the study

          -  patient with dementia

          -  preoperative breast pain

          -  preoperative opioid consumption

          -  breast reconstructive surgery

          -  bilateral surgery

          -  pregnant patient
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Olivier Verdonck, MD</last_name>
    <phone>1 844 634-3400</phone>
    <phone_ext>3808</phone_ext>
    <email>overdonck@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Yannick Verlaan, MD</last_name>
    <phone>1 844 634-3400</phone>
    <phone_ext>3808</phone_ext>
    <email>y_verlaan@hotmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hôpital Maisonneuve-Rosemont</name>
      <address>
        <city>Montréal</city>
        <state>Quebec</state>
        <zip>H1T 2M4</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yannick Verlaan, MD</last_name>
      <phone>+1(514)652-3839</phone>
      <email>y_verlaan@hotmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Nadia Godin</last_name>
      <phone>+1(844)634-3400</phone>
      <phone_ext>3808</phone_ext>
      <email>ngodin.hmr@ssss.gouv.qc.ca</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 13, 2016</study_first_submitted>
  <study_first_submitted_qc>April 15, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 18, 2016</study_first_posted>
  <last_update_submitted>March 21, 2017</last_update_submitted>
  <last_update_submitted_qc>March 21, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 22, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Maisonneuve-Rosemont Hospital</investigator_affiliation>
    <investigator_full_name>Olivier Verdonck</investigator_full_name>
    <investigator_title>Clinical Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>analgesics, opioids</keyword>
  <keyword>pectoral block</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
    <mesh_term>Epinephrine</mesh_term>
    <mesh_term>Racepinephrine</mesh_term>
    <mesh_term>Epinephryl borate</mesh_term>
    <mesh_term>Analgesics, Opioid</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

